Lasa Supergenerics Limited is engaged in manufacturing veterinary & human APIs, animal feed ingredients, and specialises in ‘catalyst chemistry’.
Financial Results:
Lasa Supergenerics Ltd reported Revenues for Q1FY24 of ₹30.56 Crores up from ₹28.88 Crore year on year, a rise of 5.82%.
Total Expenses for Q1FY24 of ₹29.53 Crores down from ₹40.09 Crores year on year, a fall of 26.34%.
Consolidated Net Profit of -₹4.95 Crores from -₹12.08 Crores in the same quarter of the previous year.
The Earnings per Share is -₹0.99, from -₹2.97 in the same quarter of the previous year.
*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.
*The presented data is automatically generated. It may occasionally generate incorrect information.